Regeneron Pharmaceuticals, Inc.
N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES
Last updated:
Abstract:
Multispecific binding molecules (MBMs) comprising an N-terminal scFv, a first Fab and a second Fab, MBM conjugates comprising the MBMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the MBMs and MBM conjugates, methods of using the MBMs, MBM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the MBMs, cells engineered to express the MBMs, and methods of producing MBMs.
Status:
Application
Type:
Utility
Filling date:
22 Apr 2022
Issue date:
11 Aug 2022